Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse D Bloom

Showing results (181-190 of 253) with videos related to

Pageof 26
Sort By:
The Journal of Infectious Diseases|February 3, 2021
Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 InfectionKatharine H D Crawford, Adam S Dingens, Rachel Eguia, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Deep mutational scanning of H5 hemagglutinin to inform influenza virus surveillanceBernadeta Dadonaite, Jenny J Ahn, Jordan T Ort, et al.
Medrxiv : the Preprint Server for Health Sciences|February 4, 2022
Dynamics of infection-elicited SARS-CoV-2 antibodies in children over timeLauren E Gentles, Leanne Kehoe, Katharine H D Crawford, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2026
Strain-specific differences in the response to egg-derived versus recombinant protein influenza vaccinesAndrea N Loes, Rosario Al Tarabi, Shuk H Li, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Mapping the specificity of H3N2 strain-specific and cross-reactive human neutralizing antibodies elicited by the 2025-2026 influenza vaccineJiaojiao Liu, Sydney Gang, Caroline Kikawa, et al.
Nature Communications|May 18, 2025
A broad antibody with enhanced HIV-1 neutralization via bispecific antibody-mediated prepositioningSoohyun Kim, Caelan E Radford, Duo Xu, et al.
Science Translational Medicine|March 5, 2025
Bispecific antibodies targeting the N-terminal and receptor binding domains potently neutralize SARS-CoV-2 variants of concernAdonis A Rubio, Viren A Baharani, Bernadeta Dadonaite, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Bispecific antibodies with broad neutralization potency against SARS-CoV-2 variants of concernAdonis A Rubio, Viren A Baharani, Bernadeta Dadonaite, et al.
Science (New York, N.Y.)|May 14, 2021
Investigate the origins of COVID-19Jesse D Bloom, Yujia Alina Chan, Ralph S Baric, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020Emma B Hodcroft, Moira Zuber, Sarah Nadeau, et al.
Pageof 26

Showing results (181-190 of 253) with videos related to

Sort By:
Pageof 26
The Journal of Infectious Diseases|February 3, 2021
Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 InfectionKatharine H D Crawford, Adam S Dingens, Rachel Eguia, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Deep mutational scanning of H5 hemagglutinin to inform influenza virus surveillanceBernadeta Dadonaite, Jenny J Ahn, Jordan T Ort, et al.
Medrxiv : the Preprint Server for Health Sciences|February 4, 2022
Dynamics of infection-elicited SARS-CoV-2 antibodies in children over timeLauren E Gentles, Leanne Kehoe, Katharine H D Crawford, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2026
Strain-specific differences in the response to egg-derived versus recombinant protein influenza vaccinesAndrea N Loes, Rosario Al Tarabi, Shuk H Li, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Mapping the specificity of H3N2 strain-specific and cross-reactive human neutralizing antibodies elicited by the 2025-2026 influenza vaccineJiaojiao Liu, Sydney Gang, Caroline Kikawa, et al.
Nature Communications|May 18, 2025
A broad antibody with enhanced HIV-1 neutralization via bispecific antibody-mediated prepositioningSoohyun Kim, Caelan E Radford, Duo Xu, et al.
Science Translational Medicine|March 5, 2025
Bispecific antibodies targeting the N-terminal and receptor binding domains potently neutralize SARS-CoV-2 variants of concernAdonis A Rubio, Viren A Baharani, Bernadeta Dadonaite, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Bispecific antibodies with broad neutralization potency against SARS-CoV-2 variants of concernAdonis A Rubio, Viren A Baharani, Bernadeta Dadonaite, et al.
Science (New York, N.Y.)|May 14, 2021
Investigate the origins of COVID-19Jesse D Bloom, Yujia Alina Chan, Ralph S Baric, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020Emma B Hodcroft, Moira Zuber, Sarah Nadeau, et al.
Pageof 26